Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
Sleep|June 1, 1987
The effect of excessive ethanol ingestion on sleep in severe chronic obstructive pulmonary diseaseP A Easton, P West, R C Meatherall, et al.Therapeutic Drug Monitoring|June 19, 1998
Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assayA D Fraser, R MeatherallJournal of Analytical Toxicology|October 12, 1999
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio studyA D Fraser, D WorthJournal of Analytical Toxicology|September 1, 1995
Evaluation of the Abbott TDx serum benzodiazepine immunoassay for the analysis of lorazepam, adinazolam, and N-desmethyladinazolamA D Fraser, W BryanJournal of Analytical Toxicology|July 1, 1996
Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off valuesA D Fraser, R MeatherallCanadian Journal of Biochemistry|September 1, 1978
Determination of the rates of synthesis and degradation of adenosine 3',5'-cyclic monophosphate in Escherichia coli CRP- and CRP+ strainsA D Fraser, H YamazakiJournal of Analytical Toxicology|March 1, 1991
Evaluation of the Abbott ADx and TDx serum benzodiazepine immunoassays for analysis of alprazolamA D Fraser, W BryanTherapeutic Drug Monitoring|December 16, 1998
Comparison of four immunoassays for the detection of lorazepam in urineR Meatherall, A D FraserCanadian Journal of Biochemistry|August 1, 1979
Effect of carbon sources on the rates of cyclic AMP synthesis, excretion, and degradation, and the ability to produce beta-galactosidase in Escherichia coliA D Fraser, H YamazakiJournal of Analytical Toxicology|October 12, 1999
Experience with a urine opiate screening and confirmation cutoff of 2000 ng/mLA D Fraser, D WorthPageof 9